InflaRx (IFRX) investors report 15.6% and 12.5% stakes in updated 13G/A
Rhea-AI Filing Summary
InflaRx N.V. received an updated Schedule 13G/A from Montanova Capital, LLC, Averill Master Fund, Ltd., and Aaron Cowen reporting significant ownership of the company’s common shares, nominal value (euro)0.12 per share. Montanova Capital and Aaron Cowen each report beneficial ownership of 22,933,910 common shares, representing 15.6% of the class, with shared voting and dispositive power over these shares and no sole power. Averill Master Fund, Ltd. reports beneficial ownership of 18,460,710 common shares, representing 12.5% of the class, also with shared voting and dispositive power only. All securities reported are directly owned by advisory clients of Montanova Capital, and, other than Averill Master Fund, no advisory client is stated to beneficially own more than 5% of the common shares. The reporting persons each disclaim beneficial ownership except to the extent of their pecuniary interest.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
beneficially owned financial
pecuniary interest financial
parent holding company financial
FAQ
What ownership stake in InflaRx N.V. (IFRX) does Montanova Capital report?
What is Aaron Cowen’s reported ownership in InflaRx (IFRX)?
Do the reporting persons on this InflaRx (IFRX) Schedule 13G/A admit full beneficial ownership?
AI-generated analysis. How Rhea-AI works. Not financial advice.